AU4571099A - Matrix metalloproteinase proenzyme activator - Google Patents
Matrix metalloproteinase proenzyme activatorInfo
- Publication number
- AU4571099A AU4571099A AU45710/99A AU4571099A AU4571099A AU 4571099 A AU4571099 A AU 4571099A AU 45710/99 A AU45710/99 A AU 45710/99A AU 4571099 A AU4571099 A AU 4571099A AU 4571099 A AU4571099 A AU 4571099A
- Authority
- AU
- Australia
- Prior art keywords
- matrix metalloproteinase
- proenzyme activator
- metalloproteinase proenzyme
- activator
- matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8950198P | 1998-06-16 | 1998-06-16 | |
US60089501 | 1998-06-16 | ||
PCT/US1999/013572 WO1999065519A1 (en) | 1998-06-16 | 1999-06-16 | Matrix metalloproteinase proenzyme activator |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4571099A true AU4571099A (en) | 2000-01-05 |
Family
ID=22217993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU45710/99A Abandoned AU4571099A (en) | 1998-06-16 | 1999-06-16 | Matrix metalloproteinase proenzyme activator |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4571099A (en) |
WO (1) | WO1999065519A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001089449A2 (en) * | 2000-05-25 | 2001-11-29 | Ben Williger | Phospholipase d effectors for therapy and screening |
US6906036B2 (en) * | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7094754B2 (en) | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7186693B2 (en) | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
US7148194B2 (en) | 2002-12-30 | 2006-12-12 | Kimberly-Clark Worldwide, Inc. | Method to increase fibronectin |
US7189700B2 (en) | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
CA3123318A1 (en) * | 2017-12-15 | 2019-06-20 | Talengen International Limited | Method and drug for preventing or treating osteoarthritis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
-
1999
- 1999-06-16 WO PCT/US1999/013572 patent/WO1999065519A1/en active Application Filing
- 1999-06-16 AU AU45710/99A patent/AU4571099A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999065519A1 (en) | 1999-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6041998A (en) | Novel prostate-associated kallikrein | |
AU7127298A (en) | Serine protease inhibitors | |
AU8858398A (en) | Matrix metalloproteinase inhibitors | |
AU4723799A (en) | Protease inhibitors | |
AU3342297A (en) | Matrix metalloproteinase inhibitors | |
AU4170499A (en) | Bleaching activator | |
AU7139598A (en) | Protease inhibitors | |
AU9059798A (en) | Urokinase inhibitors | |
AU1808999A (en) | Fibrinolytic inhibitor for sealant | |
AU4092799A (en) | Protease inhibitors | |
AU3827897A (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
IL136889A0 (en) | Matrix metalloprotease inhibitors | |
AU1393900A (en) | Morpholino-ethoxybenzofuran protease inhibitors | |
AU9110298A (en) | Protease inhibitors | |
AU2001241498A1 (en) | Matrix metalloproteinase inhibitors and uses thereof | |
AU4571099A (en) | Matrix metalloproteinase proenzyme activator | |
AU4700300A (en) | Serine proteases | |
AU1906999A (en) | Mammalian matrix-type metalloprotease | |
AU2713100A (en) | Protease inhibitors | |
AU4564499A (en) | Protease inhibitors | |
AU9300298A (en) | Protease inhibitors | |
AU6053698A (en) | Plasminogen activator as an anti-inflammatory agent | |
AU9158898A (en) | Novel metalloprotease | |
AU9747098A (en) | Aporphinoid matrix metalloproteinase inhibitors | |
AU6230398A (en) | Thrombolytic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |